KCT0006204
Recruiting
未知
ew mechanistic research on insulin resistance-related ovarian dysfunction in patients with polycystic ovary syndrome and obesity
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Gachon University Gil Medical Center
- Enrollment
- 115
- Status
- Recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Women aged 19 years or older and under 45 years old
- •\-Those who fall under one of the following three
- •1\) Patients with PCOS or obesity with amenorrhea or oligomenorrhea, who are expected to undergo obesity metabolic surgery
- •2\) Patients with PCOS or obesity with amenorrhea or oligomenrrhea menstruation and undergoing life therapy treatment or observation
- •3\) Normal control group (female reproductive function is normal and body mass index 18\.5 to 24\.9\)
- •\-Or those who collect eggs for infertility
Exclusion Criteria
- •\-Women under the age of 19 and over 45
- •\-Those who are administering hormones that affect female reproductive function other than for the purpose of collecting oocytes or have been administered within the last 6 months
- •\-Diabetic patients taking antidiabetic drugs or insulin injection treatment
- •\-Those who are administering oral contraceptives or have been given oral contraceptives within the last 6 months
- •\-Those taking antihypertensive drugs
- •\-Those who are administering anti\-obesity injections or oral drugs for the treatment of obesity, or have administered them within the last 3 months
- •\-Those who do not perform a pregnancy test or are unsure whether they are pregnant
- •\-If the average alcohol consumption per day for the past 2 years exceeded 20g (approximately 2 glasses of soju) and lasted for 3 months or more
- •\-Liver disease of other causes other than non\-alcoholic fatty liver disease
- •\-History of taking drugs that cause secondary fatty liver within the last 1 year (corticosteroids, tamoxifen, amiodarone, methotrexate, etc.)
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 1
Effects of glucocorticoids on human gut bacteriaEUCTR2016-001850-16-DKniversity of Copenhagen, The Novo Nordisk Foundation Center For Basic Metabolic Research, Section of Metabolic Genetic
Recruiting
Not Applicable
A study on the effects of insulin resistance on the effects of insulin resistance on endometrial receptivity in the treatment of spleen and kidney deficiency and yang and yang turbidity fever syndromePCOSITMCTR2024000014Beijing Hospital of Traditional Chinese Medicine, Capital Medical University
Completed
Not Applicable
Exploring the effect of disturbance in insulin metabolism on the treatment response of hepatitis C virus to find options to improve response rateHepatitis C Virus (HCV) infectionInfections and InfestationsChronic viral hepatitisISRCTN64847145Imperial College London and Imperial College Healthcare NHS Trust (UK)22
Completed
Not Applicable
A study of insulin secretion and insulin resistance using with glucose clamp techiniqueJPRN-UMIN000002359Divison of Diabetes, metabolism and Endcrinology Department of Internal Medicine, Kobe University Graduate School of Medicine90
Completed
Not Applicable
Is Insulin Resistance and/or Glucose Intolerance Pathogenetic in the Development of a Reduced Incretin EffectInsulin ResistanceGlucose IntoleranceNCT00784745University Hospital, Gentofte, Copenhagen21